NovoCure Ltd (NVCR):企業の財務・戦略的SWOT分析

◆英語タイトル:NovoCure Ltd (NVCR) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDME36072FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年1月
◆ページ数:54
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥28,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥42,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

NovoCure Ltd (NVCR) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

NovoCure Ltd (NovoCure) develops and commercializes novel delivery systems for the treatment of cancers of brain, abdomen, and torso. Its proprietary Tumor Treating Fields (TTF) technology platform uses electric fields tuned to specific frequencies for disrupting the division solid tumor cancer cells. The company markets TTF-based delivery systems: NovoTTF-100L for the treatment of malignant pleural mesothelioma; and Optune for the treatment of glioblastoma. Both of its marketed products are indicated in combination with standard chemotherapies. NovoCure is also advancing product development and clinical programs intended to improve the survival of patients with brain metastases, pancreatic cancer, ovarian cancer, liver cancer, gastric cancer, and non-small cell lung cancer. It has subsidiaries in Europe, the Middle East, Asia, and North America. NovoCure is headquartered in Saint Helier, Jersey, the UK.

NovoCure Ltd Key Recent Developments

Nov 19,2020: Novocure announces 43 presentations on tumor treating fields at Society for Neuro-Oncology 2020 Virtual Annual Meeting
Nov 10,2020: Novocure announces agenda for Virtual Research and Development Day
Nov 02,2020: Novocure announces proposed private placement of $500 million of convertible senior notes
Oct 29,2020: Novocure reports third quarter 2020 financial results and provides company update
Oct 29,2020: Novocure announces strategic alliance with NYU Grossman School of Medicine for preclinical and clinical Research

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
NovoCure Ltd – Key Facts
NovoCure Ltd – Key Employees
NovoCure Ltd – Key Employee Biographies
NovoCure Ltd – Major Products and Services
NovoCure Ltd – History
NovoCure Ltd – Company Statement
NovoCure Ltd – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
NovoCure Ltd – Business Description
Geographical Segment: EMEA
Performance
Geographical Segment: Greater China
Performance
Geographical Segment: Japan
Performance
Geographical Segment: The US
Performance
R&D Overview
NovoCure Ltd – Corporate Strategy
NovoCure Ltd – SWOT Analysis
SWOT Analysis – Overview
NovoCure Ltd – Strengths
NovoCure Ltd – Weaknesses
NovoCure Ltd – Opportunities
NovoCure Ltd – Threats
NovoCure Ltd – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
NovoCure Ltd, Medical Equipment, Deals By Year, 2015 to YTD 2021
NovoCure Ltd, Medical Equipment, Deals By Type, 2015 to YTD 2021
NovoCure Ltd, Recent Deals Summary
Section 5 – Company’s Recent Developments
Nov 19, 2020: Novocure announces 43 presentations on tumor treating fields at Society for Neuro-Oncology 2020 Virtual Annual Meeting
Nov 10, 2020: Novocure announces agenda for Virtual Research and Development Day
Nov 02, 2020: Novocure announces proposed private placement of $500 million of convertible senior notes
Oct 29, 2020: Novocure reports third quarter 2020 financial results and provides company update
Oct 29, 2020: Novocure announces strategic alliance with NYU Grossman School of Medicine for preclinical and clinical Research
Aug 13, 2020: Novocure announces expansion of its executive leadership team
Jul 30, 2020: Novocure reports second quarter 2020 financial results and provides company update
Jul 28, 2020: Novocure announces recipients of 2nd Annual AACR-Novocure grants for tumor treating fields research program
Jun 10, 2020: NovoCure announces management changes
Apr 30, 2020: Novocure reports first quarter 2020 financial results and provides company update
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
NovoCure Ltd, Key Facts
NovoCure Ltd, Key Employees
NovoCure Ltd, Key Employee Biographies
NovoCure Ltd, Major Products and Services
NovoCure Ltd, History
NovoCure Ltd, Subsidiaries
NovoCure Ltd, Key Competitors
NovoCure Ltd, Ratios based on current share price
NovoCure Ltd, Annual Ratios
NovoCure Ltd, Annual Ratios (Cont...1)
NovoCure Ltd, Interim Ratios
NovoCure Ltd, Medical Equipment, Deals By Year, 2015 to YTD 2021
NovoCure Ltd, Medical Equipment, Deals By Type, 2015 to YTD 2021
NovoCure Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[NovoCure Ltd (NVCR):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Pacific Textiles Holdings Ltd (1382):企業の財務・戦略的SWOT分析
    Pacific Textiles Holdings Ltd (1382) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Terrain Energy Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Terrain Energy Ltd (Terrain Energy) is an oil and gas company that offers oil and gas exploration and production services. The company’s services include acquiring, operations, production, management and development of oil and gas producing basins in the onshore UK. It owns and operates onsh …
  • Verrica Pharmaceuticals Inc (VRCA):製薬・医療:M&Aディール及び事業提携情報
    Summary Verrica Pharmaceuticals Inc (Verrica) is a clinical-stage medical dermatology company that discovers, develops and commercializes therapeutics for the treatment of skin diseases. The company’s lead product candidate, VP-102, is in two phase 3 clinical trials for the treatment of molluscum co …
  • University of Texas MD Anderson Cancer Center:製薬・医療:M&Aディール及び事業提携情報
    Summary University of Texas MD Anderson Cancer Center (MD Anderson) is one of the leading cancer care centers in the US. It is one of the three original comprehensive cancer care centers designated by the National Cancer Act of 1971 in the US and is affiliated to University of Texas Health. MD Ander …
  • Coca-Cola Consolidated Inc (COKE):企業の財務・戦略的SWOT分析
    Coca-Cola Consolidated Inc (COKE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Oltchim SA (OLT):企業の財務・戦略的SWOT分析
    Summary Oltchim SA (Oltchim) is a chemical company that manufactures and markets petrochemical products. The company offers inorganic, macro molecular and organic synthesis products. Its inorganic products include caustic soda, liquid chlorine, hydrochloric acid and sodium hypochlorite. Oltchim's ma …
  • Steris Corp-医療機器分野:企業M&A・提携分析
    Summary Steris Corp (Steris), formerly Innovative Medical Technologies, a subsidiary of Steris Plc, is a medical device company that offers infection prevention and other procedural products and services. The company offers surgical equipment and image management, sterile processing equipment, surgi …
  • Pharmadax Inc (4191):製薬・医療:M&Aディール及び事業提携情報
    Summary Pharmadax Inc (Pharmadax) is a drug development and generic specialty pharmaceutical company. The company develops modified release generics in various therapeutic segments. It offers products such as glyburide, quetiapine fumarate ER and metoprolol succinate ER. Pharmadax provides in the pr …
  • Virginia Electric and Power Co:企業の戦略的SWOT分析
    Virginia Electric and Power Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Credit Agricole CIB SA:企業の戦略的SWOT分析
    Credit Agricole CIB SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Sino Gas & Energy Holdings Ltd (SEH):石油・ガス:M&Aディール及び事業提携情報
    Summary Sino Gas & Energy Holdings Ltd (Sino Gas), a subsidiary of MIE Holdings Corp, is an oil and gas company that explores and develops unconventional gas assets production sharing contracts. The company holds working interest in the Linxing PSC and the Sanjiaobei PSC projects. It has strategic A …
  • Yokogawa Electric Corp (6841):企業の財務・戦略的SWOT分析
    Yokogawa Electric Corp (6841) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • ZincX Resources Corp.:企業の戦略・SWOT・財務情報
    ZincX Resources Corp. - Strategy, SWOT and Corporate Finance Report Summary ZincX Resources Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Oxiteno SA Industria E Comercio:企業の戦略的SWOT分析
    Oxiteno SA Industria E Comercio - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • UMW Holdings Berhad (UMW):石油・ガス:M&Aディール及び事業提携情報
    Summary UMW Holdings Bhd (UMW) is a diversified company. The company operates through its business divisions such as automotive, equipment, manufacturing and engineering, and oil and gas. Its automotive business manufactures, assembles, markets and distributes passenger cars and commercial vehicles. …
  • MTY Food Group Inc.:戦略・SWOT・企業財務分析
    MTY Food Group Inc. - Strategy, SWOT and Corporate Finance Report Summary MTY Food Group Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Insperity, Inc. (NSP):企業の財務・戦略的SWOT分析
    Insperity, Inc. (NSP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Currence Holding B.V.:企業の戦略・SWOT・財務情報
    Currence Holding B.V. - Strategy, SWOT and Corporate Finance Report Summary Currence Holding B.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Centra Industries, Inc.:企業の戦略・SWOT・財務情報
    Centra Industries, Inc. - Strategy, SWOT and Corporate Finance Report Summary Centra Industries, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Norton Healthcare Inc-製薬・医療分野:企業M&A・提携分析
    Summary Norton Healthcare Inc (Norton Healthcare) is a healthcare service provider that offers medical services. The center offers services such as cancer care, bariatric and weight management, diabetes and endocrine, gastroenterology, clinical trials, pain management, bone marrow transplantation, d …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆